Methylation and demethylation in the regulation of genes, cells, and responses in the immune system

Clinical Immunology

Volumn 109, Issue 1, 2003, Pages 37-45

  Fitzpatrick, David R ^a   Wilson, Christopher B ^b  

^a AMGEN INC   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLINE; CYTOKINE; DNA BINDING PROTEIN; DNA METHYLTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4;

ALLELE; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL TYPE; CHROMATIN; DEMETHYLATION; DNA METHYLATION; DNA REPLICATION; DNA STRUCTURE; EMBRYO DEVELOPMENT; GENE CONTROL; GENE EXPRESSION; HUMAN; ICF SYNDROME; IMMUNE RESPONSE; IMMUNE SYSTEM; MEMORY; NATURAL KILLER CELL; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYMOCYTE;

EID: 0142216213     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00205-5     Document Type: Article

References (133)

1. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16:2002;6-21.
2. Turner B.M. Cellular memory and the histone code. Cell. 111:2002;285-291.
3. Felsenfeld G., Groudine M. Controlling the double helix. Nature. 421:2003;448-453.
4. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genet. 33:2003;245-254.
5. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nature Rev. Genet. 3:2002;662-673.
6. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2:2002;933-944.
7. Smale S.T., Fisher A.G. Chromatin structure and gene regulation in the immune system. Annu. Rev. Immunol. 20:2002;427-462.
8. Wilson C.B., Makar K.W., Perez-Melgosa M. Epigenetic regulation of T cell fate and function. J. Infect. Dis. 185:2002;S37-45.
9. Jackson-Grusby L., Beard C., Possemato R., Tudor M., Fambrough D., Csankovszki G., Dausman J., Lee P., Wilson C., Lander E., Jaenisch R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nature Genet. 27:2001;31-39.
10. Knox J.D., Araujo F.D., Bigey P., Slack A.D., Price G.B., Zannis-Hadjopoulos M., Szyf M. Inhibition of DNA methyltransferase inhibits DNA replication. J. Biol. Chem. 275:2000;17986-17990.
11. Lee P.P., Fitzpatrick D.R., Beard C., Jessup H.K., Lehar S., Makar K.W., Perez- Melgosa M., Sweetser M.T., Schlissel M.S., Nguyen S., Cherry S.R., Tsai J.H., Tucker S.M., Weaver W.M., Kelso A., Jaenisch R., Wilson C.B. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 15:2001;763-774.
12. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:1992;915-926.
13. Robert M.F., Morin S., Beaulieu N., Gauthier F., Chute I.C., Barsalou A., MacLeod A.R. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nature Genet. 33:2003;61-65.
14. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19:1998;219-220.
15. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 99:1999;247-257.
16. Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes C.M., Gartler S.M. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA. 96:1999;14412-14417.
17. Xu G.L., Bestor T.H., Bourc'his D., Hsieh C.L., Tommerup N., Bugge M., Hulten M., Qu X., Russo J.J., Viegas-Pequignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature. 402:1999;187-191.
18. Bourc'his D., Xu G.L., Lin C.S., Bollman B., Bestor T.H. Dnmt3L and the establishment of maternal genomic imprints. Science. 294:2001;2536-2539.
19. Chedin F., Lieber M.R., Hsieh C.L. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc. Natl. Acad. Sci. USA. 99:2002;16916-16921.
20. Hata K., Okano M., Lei H., Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development. 129:2002;1983-1993.
21. Liang G., Chan M.F., Tomigahara Y., Tsai Y.C., Gonzales F.A., Li E., Laird P.W., Jones P.A. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22:2002;480-491.
22. Datta J., Ghoshal K., Sharma S.M., Tajima S., Jacob S.T. Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1. J. Cell. Biochem. 88:2003;855-864.
23. Fatemi M., Hermann A., Gowher H., Jeltsch A. Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur. J. Biochem. 269:2002;4981-4984.
24. Kim G.D., Ni J., Kelesoglu N., Roberts R.J., Pradhan S. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21:2002;4183-4195.
25. Lorincz M.C., Schubeler D., Hutchinson S.R., Dickerson D.R., Groudine M. DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation. Mol. Cell. Biol. 22:2002;7572-7580.
26. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., Cui H., Feinberg A.P., Lengauer C., Kinzler K.W., Baylin S.B., Vogelstein B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 416:2002;552-556.
27. Turker M.S. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene. 21:2002;5388-5393.
28. Di Croce L., Raker V.A., Corsaro M., Fazi F., Fanelli M., Faretta M., Fuks F., Lo Coco F., Kouzarides T., Nervi C., Minucci S., Pelicci P.G. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science. 295:2002;1079-1082.
29. Brandeis M., Frank D., Keshet I., Siegfried Z., Mendelsohn M., Nemes A., Temper V., Razin A., Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature. 371:1994;435-438.
30. Macleod D., Charlton J., Mullins J., Bird A.P. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:1994;2282-2292.
31. Lorincz M.C., Schubeler D., Goeke S.C., Walters M., Groudine M., Martin D.I. Dynamic analysis of proviral induction and de novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Mol. Cell. Biol. 20:2000;842-850.
32. Bhattacharya S.K., Ramchandani S., Cervoni N., Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature. 397:1999;579-583.
33. Detich N., Theberge J., Szyf M. Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem. 277:2002;35791-35794.
34. Thomassin H., Flavin M., Espinas M.L., Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J. 20:2001;1974-1983.
35. Voo K.S., Carlone D.L., Jacobsen B.M., Flodin A., Skalnik D.G. Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1. Mol. Cell. Biol. 20:2000;2108-2121.
36. Wolffe A.P., Jones P.L., Wade P.A. DNA demethylation. Proc. Natl. Acad. Sci. USA. 96:1999;5894-5896.
37. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18:1998;6538-6547.
38. Lewis J.D., Meehan R.R., Henzel W.J., Maurer-Fogy I., Jeppesen P., Klein F., Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 69:1992;905-914.
39. McArthur M., Thomas J.O. A preference of histone H1 for methylated DNA. EMBO J. 15:1996;1705-1714.
40. Ng H.H., Zhang Y., Hendrich B., Johnson C.A., Turner B.M., Erdjument-Bromage H., Tempst P., Reinberg D., Bird A. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nature Genet. 23:1999;58-61.
41. Prokhortchouk A., Hendrich B., Jorgensen H., Ruzov A., Wilm M., Georgiev G., Bird A., Prokhortchouk E. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15:2001;1613-1618.
42. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genet. 27:2001;322-326.
43. Hendrich B., Guy J., Ramsahoye B., Wilson V.A., Bird A. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 15:2001;710-723.
44. Hutchins A.S., Mullen A.C., Lee H.W., Sykes K.J., High F.A., Hendrich B.D., Bird A.P., Reiner S.L. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell. 10:2002;81-91.
45. Millar C.B., Guy J., Sansom O.J., Selfridge J., MacDougall E., Hendrich B., Keightley P.D., Bishop S.M., Clarke A.R., Bird A. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science. 297:2002;403-405.
46. Feng Q., Zhang Y. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev. 15:2001;827-832.
47. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278:2003;4035-4040.
48. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 393:1998;386-389.
49. Kimura H., Shiota K. Methyl-CpG-binding Protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem. 278:2003;4806-4812.
50. Tatematsu K.I., Yamazaki T., Ishikawa F. MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase. Genes Cells. 5:2000;677-688.
51. Fuks F., Burgers W.A., Brehm A., Hughes-Davies L., Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nature Genet. 24:2000;88-91.
52. Fuks F., Burgers W.A., Godin N., Kasai M., Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20:2001;2536-2544.
53. Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L., Wolffe A.P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F- responsive promoters. Nature Genet. 25:2000;338-342.
54. Rountree M.R., Bachman K.E., Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nature Genet. 25:2000;269-277.
55. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nature Rev. Immunol. 2:2002;162-174.
56. Richards E.J., Elgin S.C. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell. 108:2002;489-500.
57. Chattopadhyay S., Whitehurst C.E., Schwenk F., Chen J. Biochemical and functional analyses of chromatin changes at the TCR-beta gene locus during CD4-CD8- to CD4+CD8+ thymocyte differentiation. J. Immunol. 160:1998;1256-1267.
58. Hozumi K., Kobori A., Sato T., Nishimura T., Habu S. Transcription and demethylation of TCR beta gene initiate prior to the gene rearrangement in c-kit+ thymocytes with CD3 expression: evidence of T cell commitment in the thymus. Int. Immunol. 8:1996;1473-1481.
59. Sakamoto S., Ortaldo J.R., Young H.A. Methylation patterns of the T cell receptor beta-chain gene in T cells, large granular lymphocytes, B cells, and monocytes. J. Immunol. 140:1988;654-660.
60. Bergman Y., Fisher A., Cedar H. Epigenetic mechanisms that regulate antigen receptor gene expression. Curr. Opin. Immunol. 15:2003;176-181.
61. McMurry M.T., Krangel M.S. A role for histone acetylation in the developmental regulation of VDJ recombination. Science. 287:2000;495-498.
62. Santoso B., Ortiz B.D., Winoto A. Control of organ-specific demethylation by an element of the T-cell receptor-alpha locus control region. J. Biol. Chem. 275:2000;1952-1958.
63. Carbone A.M., Marrack P., Kappler J.W. Demethylated CD8 gene in CD4+ T cells suggests that CD4+ cells develop from CD8+ precursors. Science. 242:1988;1174-1176.
64. Hamerman J.A., Page S.T., Pullen A.M. Distinct methylation states of the CD8 beta gene in peripheral T cells and intraepithelial lymphocytes. J. Immunol. 159:1997;1240-1246.
65. Landolfi M.M., Van Houten N., Russell J.Q., Scollay R., Parnes J.R., Budd R.C. CD2- CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. J. Immunol. 151:1993;1086-1096.
66. Wu L., Pearse M., Egerton M., Petrie H., Scollay R. CD4-CD8- thymocytes that express the T cell receptor may have previously expressed CD8. Int. Immunol. 2:1990;51-56.
67. Pestano G.A., Zhou Y., Trimble L.A., Daley J., Weber G.F., Cantor H. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science. 284:1999;1187-1191.
68. Harker N., Naito T., Cortes M., Hostert A., Hirschberg S., Tolaini M., Roderick K., Georgopoulos K., Kioussis D. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol. Cell. 10:2002;1403-1415.
69. Zou Y.R., Sunshine M.J., Taniuchi I., Hatam F., Killeen N., Littman D.R. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nature Genet. 29:2001;332-336.
70. Chi T.H., Wan M., Zhao K., Taniuchi I., Chen L., Littman D.R., Crabtree G.R. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature. 418:2002;195-199.
71. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 111:2002;621-633.
72. Ballas Z.K. The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma. J. Immunol. 133:1984;7-9.
73. Bruniquel D., Schwartz R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nature Immunol. 4:2003;235-240.
74. Ward S.B., Hernandez-Hoyos G., Chen F., Waterman M., Reeves R., Rothenberg E.V. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Res. 26:1998;2923-2934.
75. Hollander G.A., Zuklys S., Morel C., Mizoguchi E., Mobisson K., Simpson S., Terhorst C., Wishart W., Golan D.E., Bhan A.K., Burakoff S.J. Monoallelic expression of the interleukin-2 locus. Science. 279:1998;2118-2121.
76. Naramura M., Hu R.J., Gu H. Mice with a fluorescent marker for interleukin 2 gene activation. Immunity. 9:1998;209-216.
77. Rao S., Gerondakis S., Woltring D., Shannon M.F. c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J. Immunol. 170:2003;3724-3731.
78. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.R., Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9:1998;229-237.
79. Gett A.V., Hodgkin P.D. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA. 95:1998;9488-9493.
80. Richter A., Lohning M., Radbruch A. Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. J. Exp. Med. 190:1999;1439-1450.
81. Fitzpatrick D.R., Shirley K.M., McDonald L.E., Bielefeldt-Ohmann H., Kay G.F., Kelso A. Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cells. J. Exp. Med. 188:1998;103-117.
82. Melvin A.J., McGurn M.E., Bort S.J., Gibson C., Lewis D.B. Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells. Eur. J. Immunol. 25:1995;426-430.
83. Penix L.A., Sweetser M.T., Weaver W.M., Hoeffler J.P., Kerppola T.K., Wilson C.B. The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J. Biol. Chem. 271:1996;31964-31972.
84. Sweetser M.T., Hoey T., Sun Y.L., Weaver W.M., Price G.A., Wilson C.B. The roles of nuclear factor of activated T cells and ying-yang 1 in activation-induced expression of the interferon-gamma promoter in T cells. J. Biol. Chem. 273:1998;34775-34783.
85. White G.P., Watt P.M., Holt B.J., Holt P.G. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J. Immunol. 168:2002;2820-2827.
86. Young H.A., Ghosh P., Ye J., Lederer J., Lichtman A., Gerard J.R., Penix L., Wilson C.B., Melvin A.J., McGurn M.E. Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J. Immunol. 153:1994;3603-3610.
87. Fitzpatrick D.R., Shirley K.M., Kelso A. Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8+ T lymphocytes. J. Immunol. 162:1999;5053-5057.
88. Mikovits J.A., Young H.A., Vertino P., Issa J.P., Pitha P.M., Turcoski-Corrales S., Taub D.D., Petrow C.L., Baylin S.B., Ruscetti F.W. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol. Cell. Biol. 18:1998;5166-5177.
89. Fang J.Y., Mikovits J.A., Bagni R., Petrow-Sadowski C.L., Ruscetti F.W. Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J. Virol. 75:2001;9753-9761.
90. Agarwal S., Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 9:1998;765-775.
91. Bix M., Locksley R.M. Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. Science. 281:1998;1352-1354.
92. Grogan J.L., Mohrs M., Harmon B., Lacy D.A., Sedat J.W., Locksley R.M. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity. 14:2001;205-215.
93. Guo L., Hu-Li J., Zhu J., Watson C.J., Difilippantonio M.J., Pannetier C., Paul W.E. In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production. Proc. Natl. Acad. Sci. USA. 99:2002;10623-10628.
94. Lee D.U., Agarwal S., Rao A. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity. 16:2002;649-660.
95. Riviere I., Sunshine M.J., Littman D.R. Regulation of IL-4 expression by activation of individual alleles. Immunity. 9:1998;217-228.
96. Santangelo S., Cousins D.J., Winkelmann N.E., Staynov D.Z. DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4(+) T cell differentiation. J. Immunol. 169:2002;1893-1903.
97. Hu-Li J., Pannetier C., Guo L., Lohning M., Gu H., Watson C., Assenmacher M., Radbruch A., Paul W.E. Regulation of expression of IL-4 alleles: analysis using a chimeric GFP/IL-4 gene. Immunity. 14:2001;1-11.
98. Avni O., Lee D., Macian F., Szabo S.J., Glimcher L.H., Rao A. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nature Immunol. 3:2002;643-651.
99. Fields P.E., Kim S.T., Flavell R.A. Cutting edge: changes in histone acetylation at the IL- 4 and IFN-gamma loci accompany Th1/Th2 differentiation. J. Immunol. 169:2002;647-650.
100. Zhou M., Ouyang W., Gong Q., Katz S.G., White J.M., Orkin S.H., Murphy K.M. Friend of GATA-1 represses GATA-3-dependent activity in CD4+ T cells. J. Exp. Med. 194:2001;1461-1471.
101. Lembo F., Pero R., Angrisano T., Vitiello C., Iuliano R., Bruni C.B., Chiariotti L. MBDin, a novel MBD2-interacting protein, relieves MBD2 repression potential and reactivates transcription from methylated promoters. Mol. Cell. Biol. 23:2003;1656-1665.
102. Zhu J., Guo L., Min B., Watson C.J., Hu-Li J., Young H.A., Tsichlis P.N., Paul W.E. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity. 16:2002;733-744.
103. Kimura M., Koseki Y., Yamashita M., Watanabe N., Shimizu C., Katsumoto T., Kitamura T., Taniguchi M., Koseki H., Nakayama T. Regulation of Th2 cell differentiation by mel-18, a mammalian polycomb group gene. Immunity. 15:2001;275-287.
104. Avni O., Rao A. T cell differentiation: a mechanistic view. Curr. Opin. Immunol. 12:2000;654-659.
105. Fitzpatrick D.R., Kelso A. Nature versus nurture in T cell cytokine production. J Leukocyte Biol. 66:1999;869-875.
106. Glimcher L.H., Murphy K.M. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14:2000;1693-1711.
107. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
108. Bix M., Wang Z.E., Thiel B., Schork N.J., Locksley R.M. Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism. J. Exp. Med. 188:1998;2289-2299.
109. Gorham J.D., Guler M.L., Steen R.G., Mackey A.J., Daly M.J., Frederick K., Dietrich W.F., Murphy K.M. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl. Acad. Sci. USA. 93:1996;12467-12472.
110. Loots G.G., Locksley R.M., Blankespoor C.M., Wang Z.E., Miller W., Rubin E.M., Frazer K.A. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science. 288:2000;136-140.
111. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2:2001;675-680.
112. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nature Immunol. 1:2000;199-205.
113. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science. 290:2000;92-97.
114. Lohning M., Richter A., Radbruch A. Cytokine memory of T helper lymphocytes. Adv. Immunol. 80:2002;115-181.
115. Kaech S.M., Hemby S., Kersh E., Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell. 111:2002;837-851.
116. Messi M., Giacchetto I., Nagata K., Lanzavecchia A., Natoli G., Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nature Immunol. 4:2003;78-86.
117. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., von .Andrian U.H., Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunol. 4:2003;225-234.
118. Chan H.W., Kurago Z.B., Stewart C.A., Wilson M.J., Martin M.P., Mace B.E., Carrington M., Trowsdale J., Lutz C.T. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 197:2003;245-255.
119. Held W., Coudert J.D., Zimmer J. The NK cell receptor repertoire: formation, adaptation and exploitation. Curr. Opin. Immunol. 15:2003;233-237.
120. Santourlidis S., Trompeter H.I., Weinhold S., Eisermann B., Meyer K.L., Wernet P., Uhrberg M. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169:2002;4253-4261.
121. Landmann S., Muhlethaler-Mottet A., Bernasconi L., Suter T., Waldburger J.M., Masternak K., Arrighi J.F., Hauser C., Fontana A., Reith W. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J. Exp. Med. 194:2001;379-391.
122. van den Elsen P.J., van der Stoep N., Vietor H.E., Wilson L., van Zutphen M., Gobin S.J. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA. Hum. Immunol. 61:2000;850-862.
123. Morris A.C., Spangler W.E., Boss J.M. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control. J. Immunol. 164:2000;4143-4149.
124. Morris A.C., Beresford G.W., Mooney M.R., Boss J.M. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol. Cell. Biol. 22:2002;4781-4791.
125. Pattenden S.G., Klose R., Karaskov E., Bremner R. Interferon-gamma- induced chromatin remodeling at the CIITA locus is BRG1 dependent. EMBO J. 21:2002;1978-1986.
126. Beresford G.W., Boss J.M. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nature Immunol. 2:2001;652-657.
127. Masternak K., Peyraud N., Krawczyk M., Barras E., Reith W. Chromatin remodeling and extragenic transcription at the MHC class II locus control region. Nature Immunol. 4:2003;132-137.
128. Clark S.J., Harrison J., Paul C.L., Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22:1994;2990-2997.
129. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Blake C., Shibata D., Danenberg P.V., Laird P.W. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28:2000;E32-E38.
130. Ranish J.A., Yi E.C., Leslie D.M., Purvine S.O., Goodlett D.R., Eng J., Aebersold R. The study of macromolecular complexes by quantitative proteomics. Nature Genet. 33:2003;349-355.
131. Festenstein R., Pagakis S.N., Hiragami K., Lyon D., Verreault A., Sekkali B., Kioussis D. Modulation of heterochromatin protein 1 dynamics in primary mammalian cells. Science. 299:2003;719-721.
132. Cheng J.C., Matsen C.B., Gonzales F.A., Ye W., Greer S., Marquez V.E., Jones P.A., Selker E.U. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J. Natl. Cancer Inst. 95:2003;399-409.
133. Rando O.J., Chi T.H., Crabtree G.R. Second messenger control of chromatin remodeling. Nature Struct. Biol. 10:2003;81-83.